Phelcom Technologies was one of the companies invited to participate in the International Seminar on Innovative Startups in the Area of Health and Inclusion, which took place on November 23 in São Paulo.
The meeting presented the startups business models developed during the Startups Training and Development of People with Disabilities course offered by the São Paulo State Departament for the Rights of Persons with Disabilities in partnership with the University of São Paulo (USP).
In addition to Phelcom, the international companies Renew Senses and Cure Medical were also some of the invited startups.
Phelcom co-founder and CEO José Augusto Stuchi presented the Eyer portable retinal camera, an innovative smartphone device that performs high quality exams. “Portability and low cost compared to the traditional fundus camera democratizes access to retinal examination, helping to prevent and diagnose blindness and severe visual impairment, diseases that affect about 250 million people in the world,” says Stuchi.
Today, 85% of Brazilian cities do not have ophthalmology services. With Eyer, the exams can be done anywhere and the generated data will be automatically synchronized with the internet, allowing the remote diagnosis.
The equipment is expected to be launched in early 2019.
Phelcom Technologies participated in the 21st National Free Diabetes Prevention Campaign, sponsored by the National Association of Diabetes Care (Anad), from November 7 to 14 in São Paulo, in partnership with the Instituto da Visão (Ipepo), Federal University of São Paulo (Unifesp) and the German multinational Bayer. The event is related to the World Diabetes Day, celebrated on November 14.
At the time, the Brazilian startup examined about 500 patients with the portable fundus camera Eyer, an innovative product with high technology that will be launched soon by the company. “One of the chronic complications of diabetes is diabetic retinopathy, an early-stage asymptomatic disease that can cause severe visual impairment or even blindness when not diagnosed,” said Phelcom’s co-founder and CTO, Diego Lencione, who represented the company in this event.
More than 18 million people have diabetes in Brazil. The number may be higher because many cases have not yet been identified. “Today, almost 85% of Brazilian cities do not have access to ophthalmologists and ophthalmological devices that help diagnose the disease and its complications. Our objective with this portable device is to enable the care of communities that have limited access to this type of examination,” says Lencione.
Exams performed by the Phelcom portable retinal camera facilitated the diagnosis of retinal lesions and early referral for proper treatment of many patients during the task force.
Eyer
Eyer is a portable retinal camera developed by Phelcom Technologies that aims to help combat severe visual impairment and blindness, which affect more than 250 million people worldwide. Currently, 75% of cases occur due to lack of prevention, early diagnosis and correct treatment.
Português 
Español 
English 
